A-19 (SOLENOPSIS INVICTA, PERIPLANETA AMERICANA, MUSCA DOMESTICA, BOMBYX MORI WHOLE, and AEDES TAENIORHYNCHUS)
**Product type:** Human Otc Drug
**Active ingredient:** AEDES TAENIORHYNCHUS; BOMBYX MORI WHOLE; MUSCA DOMESTICA; PERIPLANETA AMERICANA; SOLENOPSIS INVICTA
**Strength:** 30; 30; 30; 30; 30 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
**Dosage form:** Solution
**Route:** Sublingual
**Labeler:** DNA Labs, Inc.
**Marketing category:** UNAPPROVED HOMEOPATHIC
**Pharmacologic class:** Allergens [CS], Allergens [CS], Allergens [CS], Allergens [CS], Ant Venoms [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Insect Proteins [CS], Insect Proteins [CS], Insect Proteins [CS], Insect Proteins [CS], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Allergenic Extract [EPC], Non-Standardized Insect Venom Allergenic Extract [EPC]
/api/v1/systems/ndc_fda/nodes/58264-0311Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.